# Diamel in the Treatment of Polycystic Ovary Syndrome

> **NCT01051024** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 110 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Diamel
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01051024
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051024, "Diamel in the Treatment of Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01051024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*